Multiple myeloma in a young patient
DOI:
https://doi.org/10.61997/bjm.v13i1.405Keywords:
multiple myeloma, protein electrophoresis, osteolytic lesions, treatmentAbstract
Multiple myeloma is a type B blood cancer characterized by clonal proliferation of malignant plasma cells. The median age at diagnosis is 70 years, however, it is rare among younger patients, and less than 0.5% are younger than 30 years. A 33-year-old man, who began with progressive acute kidney injury is presented, accompanied by a severe lower back pain and impossibility to walk. A dorso-lumbar spine CT scan showed an extensive process consisting of multiple osteolytic lesions at T12, L2, ribs, pelvic and proximal femur. Radiology, along with histology, bone marrow aspiration and protein electrophoresis analysis allowed to establish the diagnosis of stage III multiple myeloma, after which the patient received chemotherapy. Despite the rarity of multiple myeloma among young patients, this diagnosis should be evoked when clinical, biological and radiological signs are in favour. There appears to be no difference between younger and older patients in disease presentation, although longer survival was reported among younger patients.
Downloads
References
Kyle RA. Rajkumar SV. Multiple myeloma. Blood. 2008; 111(6): 2962–72. Available at: https://doi.org/10.1182/blood-2007-10-078022 DOI: https://doi.org/10.1182/blood-2007-10-078022
Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011; 364(11): 1046-60. Available at: https://www.nejm.org/doi/full/10.1056/NEJMra1011442
Man HV, Dung PC. A case of multiple myeloma in a 17-year-old girl treated with autologous hematopoietic stem cell transplantation (ASCT). Am J Case Rep. 2019; 20: 1623-9. Available at: https://doi.org/10.12659/AJCR.917670 DOI: https://doi.org/10.12659/AJCR.917670
Fairfield H, Falank C, Avery L, Reagan MR. Multiple myeloma in the marrow: pathogenesis and treatments. Ann N Y Acad Sci. 2016; 1364(1): 32-51. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806534/
Kazandjian D. Multiple myeloma epidemiology and survival: A unique malignancy. Semin Oncol. 2016; 43(6):676-81. Available at: http://doi.org/10.1053/j.seminoncol.2016.11.004 DOI: https://doi.org/10.1053/j.seminoncol.2016.11.004
Lassiter G, Bergeron C, Guedry R, Cucarola J, Kaye AM, Cornett EM, et al. Belantamab Mafodotin to Treat Multiple Myeloma: A Comprehensive Review of Disease, Drug Efficacy and Side Effects. Curr Oncol. 2021; 28(1):640-60. Available at: https://doi.org/10.3390%2Fcurroncol28010063 DOI: https://doi.org/10.3390/curroncol28010063
Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011; 364(11):1046-60. Available at: https://doi.org/10.1056/nejmra1011442 DOI: https://doi.org/10.1056/NEJMra1011442
Fairfield H, Falank C, Avery L, Reagan MR. Multiple myeloma in the marrow: pathogenesis and treatments. Ann N Y Acad Sci. 2016; 1364(1):32-51. Available at: http://doi.org/10.1111/nyas.13038 DOI: https://doi.org/10.1111/nyas.13038
Koshiaris C, Van den Bruel A, Oke JL, Nicholson BD, Shephard E, Braddick M, et al. Early detection of multiple myeloma in primary care using blood tests: a case-control study in primary care. Br J Gen Pract. 2018; 68(674):e586-e593. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104875/ DOI: https://doi.org/10.3399/bjgp18X698357
Kristinsson SY, Minter AR, Korde N, Tan E, Landgren O. Bone disease in multiple myeloma and precursor disease: novel diagnostic approaches and implications on clinical management. Expert Rev Mol Diagn. 2011; 11(6):593-603. Available at: http://doi.org/10.1586/erm.11.44 DOI: https://doi.org/10.1586/erm.11.44
Valković T, Gačić V, Ivandić J, Petrov B, Dobrila-Dintinjana R, Dadić-Hero E, et al. Infections in hospitalised patients with multiple myeloma: main characteristics and risk factors. Turk J Haematol. 2015; 32(3):234-42. http://doi.org/10.4274/tjh.2013.0173 DOI: https://doi.org/10.4274/tjh.2013.0173
Usha, Agarwal N, Kumar P, Rai M, Singh RG, Seth M, Saraf SK. Myeloma in young age. Indian J Pathol Microbiol. 2005; 48(3):314-7. Available at: https://pubmed.ncbi.nlm.nih.gov/16761740/
Blade J, Kyle RA, Greipp PR. Multiple myeloma in patients younger than 30 years. Report of 10 cases and review of the literature. Arch Intern Med. 1996; 156:1463–68. Available at: http://doi.org/10.1001/archinte.1996.00440120125014 DOI: https://doi.org/10.1001/archinte.156.13.1463
Miceli TS, Colson K, Faiman BM, Miller K, Tariman JD; International Myeloma Foundation Nurse Leadership Board. Maintaining bone health in patients with multiple myeloma: survivorship care plan of the International Myeloma Foundation Nurse Leadership Board. Clin J Oncol Nurs. 2011; 15 Suppl(0):9-23. Available at: http://doi.org/10.1188/11.S1.CJON.9-23 DOI: https://doi.org/10.1188/11.S1.CJON.9-23
Gastelum ZN, Biggs DM, Scott A. Multiple Myeloma Presenting as Acute Renal Failure in the Absence of Other Characteristic Features. Cureus. 2017; 9(9):e1703. Available at: http://doi.org/10.7759/cureus.1703 DOI: https://doi.org/10.7759/cureus.1703
Coluzzi F, Rolke R, Mercadante S. Pain management in patients with multiple myeloma: an pdate. Cancers (Basel). 2019; 11(12):2037. Available at: http://doi.org/10.3390/cancers11122037 DOI: https://doi.org/10.3390/cancers11122037
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Miguel Ricardo Quetzal, Jorge Soler González
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
BJM protects Copyright at all times. However, it gives up part of the rights by displaying a Creative Commons License 4.0 (cc-by-nc), which allows the use of the work to share (copy and redistribute the material in any support or format) and adapt (transform and built from the material) as long as exclusive mention of the publication in the journal as the primary source is made. Under no circumstances, the work can be commercialized.
